167 related articles for article (PubMed ID: 26844285)
1. Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis.
Mishima K; Kitoh H; Ohkawara B; Okuno T; Ito M; Masuda A; Ishiguro N; Ohno K
EBioMedicine; 2015 Dec; 2(12):2046-61. PubMed ID: 26844285
[TBL] [Abstract][Full Text] [Related]
2. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
[TBL] [Abstract][Full Text] [Related]
3. l-Quebrachitol Promotes the Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells: Involvement of the BMP-2/Runx2/MAPK/Wnt/β-Catenin Signaling Pathway.
Yodthong T; Kedjarune-Leggat U; Smythe C; Wititsuwannakul R; Pitakpornpreecha T
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486330
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-α enhances the transcription of Smad ubiquitination regulatory factor 1 in an activating protein-1- and Runx2-dependent manner.
Lee HL; Yi T; Baek K; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2013 May; 228(5):1076-86. PubMed ID: 23042144
[TBL] [Abstract][Full Text] [Related]
7. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK.
Lee HW; Suh JH; Kim HN; Kim AY; Park SY; Shin CS; Choi JY; Kim JB
J Bone Miner Res; 2008 Aug; 23(8):1227-37. PubMed ID: 18410224
[TBL] [Abstract][Full Text] [Related]
8. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
9. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
Lu Z; Wang G; Dunstan CR; Zreiqat H
Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
[TBL] [Abstract][Full Text] [Related]
10. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
11. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
12. Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation.
Wagley Y; Chesi A; Acevedo PK; Lu S; Wells AD; Johnson ME; Grant SFA; Hankenson KD
Stem Cells; 2020 Oct; 38(10):1332-1347. PubMed ID: 32535942
[TBL] [Abstract][Full Text] [Related]
13. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
Nat Commun; 2013; 4():2562. PubMed ID: 24096742
[TBL] [Abstract][Full Text] [Related]
14. LIM Mineralization Protein-1 Enhances Bone Morphogenetic Protein-2-Mediated Osteogenesis Through Activation of ERK1/2 MAPK Pathway and Upregulation of Runx2 Transactivity.
Pan H; Li X; Wang J; Zhang K; Yang H; Li Z; Zheng Z; Liu H
J Bone Miner Res; 2015 Aug; 30(8):1523-35. PubMed ID: 25677945
[TBL] [Abstract][Full Text] [Related]
15. Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation.
Chen IT; Hsu PH; Hsu WC; Chen NJ; Tseng PH
Sci Rep; 2015 Jul; 5():12300. PubMed ID: 26189595
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation.
Zhu W; He X; Hua Y; Li Q; Wang J; Gan X
J Biol Chem; 2017 Jul; 292(27):11178-11188. PubMed ID: 28500134
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation.
Lin KL; Chou CH; Hsieh SC; Hwa SY; Lee MT; Wang FF
J Bone Miner Res; 2010 Nov; 25(11):2489-503. PubMed ID: 20564243
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
[TBL] [Abstract][Full Text] [Related]
19. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
Li J; Hao L; Wu J; Zhang J; Su J
Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Runx2 phosphorylation sites required for TGF-β1-mediated stimulation of matrix metalloproteinase-13 expression in osteoblastic cells.
Arumugam B; Vairamani M; Partridge NC; Selvamurugan N
J Cell Physiol; 2018 Feb; 233(2):1082-1094. PubMed ID: 28419442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
